<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To investigate the effects of hematopoietic growth factors (HGFs) on <z:mpath ids='MPATH_3'>apoptosis</z:mpath> of hematopoietic cells in <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) patients </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: CD34+ cells in bone marrow from 12 MDS patients were purified by an immunomagnetic beads sorting system </plain></SENT>
<SENT sid="2" pm="."><plain><z:mpath ids='MPATH_3'>Apoptosis</z:mpath> of hematopoietic precursors was assayed by <z:chebi fb="0" ids="51246">propidium</z:chebi> <z:chebi fb="60" ids="24859">iodine</z:chebi> staining and flow cytometric analysis </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS AND CONCLUSION: High dose rhEpo partly suppressed <z:mpath ids='MPATH_3'>apoptosis</z:mpath> of hematopoietic cells in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients </plain></SENT>
<SENT sid="4" pm="."><plain>At the 7th, 10th, 14th, cultured day, the apoptotic percentages of the high dose Epo group (rhEpo 200 U/ml or 100 U/ml) were substantially lower than that of the low dose group (20 U/ml, 2 U/ml and 0.2 U/ml) and showed a dose-dependent effect with rhEpo </plain></SENT>
<SENT sid="5" pm="."><plain>rhGM-CSF and rhIL-3 could also suppress hematopoietic cell <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in vitro, the differences between the high dose group (rhIL-3 200 U/ml or rhGM-CSF 500 U/ml) and the low dose group (rhIL-3 50 U/ml or rhGM-CSF 50 U/ml) were significant </plain></SENT>
<SENT sid="6" pm="."><plain>Extensive <z:mpath ids='MPATH_3'>apoptosis</z:mpath> of myelodysplastic hematopoietic cells were markely suppressed when rhEpo and rhIL-3 or rhEpo and rhGM-CSF were given together </plain></SENT>
</text></document>